BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35182476)

  • 21. p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells.
    Mardaryev AN; Gdula MR; Yarker JL; Emelianov VU; Poterlowicz K; Sharov AA; Sharova TY; Scarpa JA; Joffe B; Solovei I; Chambon P; Botchkarev VA; Fessing MY
    Development; 2014 Jan; 141(1):101-11. PubMed ID: 24346698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional repression of Gata3 is essential for early B cell commitment.
    Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D
    Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
    Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
    Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.
    Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G
    Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
    Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
    Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Interplay of Transcription and Genome Topology Programs T Cell Development and Differentiation.
    Zhao X; Zhu S; Peng W; Xue HH
    J Immunol; 2022 Dec; 209(12):2269-2278. PubMed ID: 36469845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
    Bayer M; Grosschedl R
    Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
    Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
    Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
    Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
    Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of relapse of adult T cell acute lymphoblastic leukemia.
    Sentís I; Gonzalez S; Genescà E; García-Hernández V; Muiños F; Gonzalez C; López-Arribillaga E; Gonzalez J; Fernandez-Ibarrondo L; Mularoni L; Espinosa L; Bellosillo B; Ribera JM; Bigas A; Gonzalez-Perez A; Lopez-Bigas N
    Genome Biol; 2020 Nov; 21(1):284. PubMed ID: 33225950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBF1 primes B-lymphoid enhancers and limits the myeloid bias in murine multipotent progenitors.
    Lenaerts A; Kucinski I; Deboutte W; Derecka M; Cauchy P; Manke T; Göttgens B; Grosschedl R
    J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36048017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.
    Treiber T; Mandel EM; Pott S; Györy I; Firner S; Liu ET; Grosschedl R
    Immunity; 2010 May; 32(5):714-25. PubMed ID: 20451411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBF1 is continuously required for stabilizing local chromatin accessibility in pro-B cells.
    Zolotarev N; Bayer M; Grosschedl R
    Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2210595119. PubMed ID: 36409886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
    Zhang ZJ; Wu QF; Ren AQ; Chen Q; Shi JZ; Li JP; Liu XY; Zhang ZJ; Tang YZ; Zhao Y; Yao NN; Zhang XY; Liu CP; Dong G; Zhao JX; Xu MJ; Yue YQ; Hu J; Sun F; Liu Y; Ao QL; Zhou FL; Wu H; Zhang TC; Zhu HC
    Acta Pharmacol Sin; 2023 Nov; 44(11):2282-2295. PubMed ID: 37280363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
    Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
    PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.
    Zandi S; Mansson R; Tsapogas P; Zetterblad J; Bryder D; Sigvardsson M
    J Immunol; 2008 Sep; 181(5):3364-72. PubMed ID: 18714008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.